Breakthrough T1d

Analysis

Breakthrough T1d is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in April 1973, 53 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Breakthrough T1d reported income of $223.8m and spending of $215.8m, spending 96% of its income. Across the 5 years on record, from June 2019 to June 2023, income fell from $239.3m to $223.8m (-6.5%), an average of -1.7% a year. Over the whole period it spent 79% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Breakthrough T1d sits at the 97th percentile: it is larger than about 97% of them. Against every charity in United States with reported income it ranks in the 100th percentile, and in the 99th percentile within NY. Charities of a similar size with the same main cause include Phoebe Physician Group Inc ($223.6m), St Lukes Hospital-Monroe Campus ($225.2m) and University Hospital & Clinics Inc ($222.7m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 85% and program service revenue 8.8% of the total. Compensation of current officers, directors and key employees was $4.3m (2.0% of expenses). Other salaries and wages came to $52.3m. It paid $2.4m in professional fundraising fees. At year end it held assets of $446.2m against liabilities of $139.0m, net assets of $307.2m. It reported 570 employees.